NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
Find a Tender
Type
Framework (Goods)
Duration
1 year (est.)
Value
£1
Sector
HEALTH
Published
23 Feb 2021
Delivery
01 Mar 2021 to 28 Feb 2022 (est.)
Deadline
n/a

Related Terms

Location

United Kingdom: Please refer to Document No. 10 for a full list of participating authorities

Geochart for 1 buyers and 56 suppliers

1 buyer

37 suppliers

Description

CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20/5591/02 - Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 monthsCM/PHR/20/5591/03 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021CM/PHR/20/5591/04 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021

Lot Division

1 Midlands and East (MAE) Tranche B

CM/PHR/20/5591/01 - NHS Framework for the Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
2 Midlands and East Cytokine Modulators and other monoclonal antibodies

CM/PHR/20/5591/02 - NHS Framework for the Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
3 LNW) – Interleukin Inhibitors, JAK Inhibitors, Migraine & Asthma

CM/PHR/20/5591/03 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
4 SOFE) – Interleukin Inhibitors, JAK Inhibitors, Migraine & Asthma

CM/PHR/20/5591/04 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Award Detail

1 Accord (Barnstaple)
  • Reference: 003581-2021-1
  • Value: £1
2 Aventis Pharma (Reading)
  • Reference: 003581-2021-2
  • Value: £1
3 Bayer (Reading)
  • Reference: 003581-2021-3
  • Value: £1
4 Biogen (Maidenhead)
  • Reference: 003581-2021-4
  • Value: £1
5 Bristol Myers Squibb (Uxbridge)
  • Reference: 003581-2021-5
  • Value: £1
6 Celltrion Healthcare (Slough)
  • Reference: 003581-2021-6
  • Value: £1
7 CST Pharma (Walsall)
  • Reference: 003581-2021-7
  • Value: £1
8 Daiichi Sankyo (Uxbridge)
  • Reference: 003581-2021-8
  • Value: £1
9 Day Lewis Medical (Croydon)
  • Reference: 003581-2021-9
  • Value: £1
10 Drreddys Laboratories (Beverley)
  • Reference: 003581-2021-10
  • Value: £1
11 Eli Lilly (Basingstoke)
  • Reference: 003581-2021-11
  • Value: £1
12 Leo Pharma (Hurley)
  • Reference: 003581-2021-12
  • Value: £1
13 Ferring Pharmaceuticals (West Drayton)
  • Reference: 003581-2021-13
  • Value: £1
14 Gilead Sciences (London)
  • Reference: 003581-2021-14
  • Value: £1
15 Ipsen (Slough)
  • Reference: 003581-2021-15
  • Value: £1
16 Merck Serono (Feltham)
  • Reference: 003581-2021-16
  • Value: £1
17 Merck Sharpe & Dohme (Hoddesdon)
  • Reference: 003581-2021-17
  • Value: £1
18 Mylan (Potters Bar)
  • Reference: 003581-2021-18
  • Value: £1
19 Napp Pharmaceuticals (Cambridge)
  • Reference: 003581-2021-19
  • Value: £1
20 Novo Nordisk (Gatwick)
  • Reference: 003581-2021-20
  • Value: £1
21 Roche Products (Welwyn Garden City)
  • Reference: 003581-2021-21
  • Value: £1
22 Rovi Biotech (Croydon)
  • Reference: 003581-2021-22
  • Value: £1
23 Novartis Pharmaceuticals (London)
  • Reference: 003581-2021-23
  • Value: £1
24 Pfizer (Sandwich)
  • Reference: 003581-2021-24
  • Value: £1
25 Sandoz (Surrey)
  • Reference: 003581-2021-25
  • Value: £1
26 Techdow Pharma England (Guildford)
  • Reference: 003581-2021-26
  • Value: £1
27 Takeda (London)
  • Reference: 003581-2021-27
  • Value: £1
28 Teva (Castleford)
  • Reference: 003581-2021-28
  • Value: £1
29 Ul Global Pharma (Watford)
  • Reference: 003581-2021-29
  • Value: £1
30 Bristol Myers Squibb (Uxbridge)
  • Reference: 003581-2021-30
  • Value: £1
31 Celltrion Healthcare (Slough)
  • Reference: 003581-2021-31
  • Value: £1
32 Eli Lilly (Basingstoke)
  • Reference: 003581-2021-32
  • Value: £1
33 Astrazeneca (Luton)
  • Reference: 003581-2021-33
  • Value: £1
34 Merck Sharpe & Dohme (Hoddesdon)
  • Reference: 003581-2021-34
  • Value: £1
35 Napp Pharmaceuticals (Cambridge)
  • Reference: 003581-2021-35
  • Value: £1
36 Novartis Pharmaceuticals (London)
  • Reference: 003581-2021-36
  • Value: £1
37 Pfizer (Sandwich)
  • Reference: 003581-2021-37
  • Value: £1
38 Roche Products (Welwyn Garden City)
  • Reference: 003581-2021-38
  • Value: £1
39 Teva (Castleford)
  • Reference: 003581-2021-39
  • Value: £1
40 Takeda (London)
  • Reference: 003581-2021-40
  • Value: £1
41 Amgen (Cambridge)
  • Reference: 003581-2021-41
  • Value: £1
42 Gedeon Richter (London)
  • Reference: 003581-2021-42
  • Value: £1
43 Thornton & Ross (Huddersfield)
  • Reference: 003581-2021-43
  • Value: £1
44 Ucb Pharma (Slough)
  • Reference: 003581-2021-44
  • Value: £1
45 Janssen Cilag (High Wycombe)
  • Reference: 003581-2021-45
  • Value: £1
46 Merck Sharp & Dohme MSD (Hoddesdon)
  • Reference: 003581-2021-46
  • Value: £1
47 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • Reference: 003581-2021-47
  • Value: £1
48 Eli Lilly (Basingstoke)
  • Reference: 003581-2021-48
  • Value: £1
49 Astrazeneca (Luton)
  • Reference: 003581-2021-49
  • Value: £1
50 Teva (Castleford)
  • Reference: 003581-2021-50
  • Value: £1
51 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • Reference: 003581-2021-51
  • Value: £1
52 Eli Lilly (Basingstoke)
  • Reference: 003581-2021-52
  • Value: £1
53 Novartis Pharmaceuticals (London)
  • Reference: 003581-2021-53
  • Value: £1
54 Teva (Castleford)
  • Reference: 003581-2021-54
  • Value: £1
55 Astrazeneca (Luton)
  • Reference: 003581-2021-55
  • Value: £1
56 Sobi Swedish Orphan Biovitrum (Cambridgeshire)
  • Reference: 003581-2021-56
  • Value: £1

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-029565
  • FTS 003581-2021

Domains